welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Anna Mayhew, PhD

Consultant Research Physiotherapist
MRC Centre for Neuromuscular Diseases at Newcastle
Newcastle University
Centre for Life
Central Parkway
Newcastle upon Tyne, United Kingdom

Anna Mayhew is a Consultant Research Physiotherapist at The MRC Centre for Neuromuscular Diseases at Newcastle University. She is involved in clinical and research activity for children and adults. Prior to this, she was Network Coordinator for Smartnet, a UK based project on the collection of clinical measures for Spinal Muscular Atrophy (SMA). She is also involved in training clinical evaluators for clinical trials both in Duchenne Muscular Dystrophy (DMD) and Spinal Muscular Atrophy and in the ongoing development of clinically relevant measures for use in neuromuscular trials.

Anna initially specialised in paediatrics and neonates and then gained a PhD in predicting outcome in preterm infants. Anna has published several articles on the development of outcome measures for use in various neuromuscular diseases (NMDs) including DMD and SMA. She is also a consultant for various pharmaceutical companies specifically relating to clinical evaluation including Prosensa, PTC and ISIS.


Representative Publications:

Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data

Quantitative Evaluation of Lower Extremity Joint Contractures in Spinal Muscular Atrophy: Implications for Motor Function

Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials

Update on Standard Operating Procedures in Preclinical Research for DMD and SMA Report of TREAT-NMD Alliance Workshop, Schiphol Airport, 26 April 2015, The Netherlands

Psychometric analysis of the pediatric quality of life inventory 3.0 neuromuscular module administered to patients with duchenne muscular dystrophy: A rasch analysis

Psychometric properties of the Zarit Caregiver Burden Interview administered to caregivers to patients with Duchenne muscular dystrophy: a Rasch analysis